Omnicell (OMCL) Other Non-Current Assets (2010 - 2026)
Omnicell's (OMCL) quarterly Other Non-Current Assets came in at $65.7 million in Q2 2026, down 8.85% year-over-year from $72.0 million in Q2 2025, and down 2.8% quarter-over-quarter from $67.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Other Non-Current Assets for 17 consecutive years, with $65.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 8.85% year-over-year to $65.7 million in Q2 2026; TTM through Jun 2026 was $65.7 million, a 8.85% decrease from a year earlier, with the FY2025 full-year figure at $70.2 million, down 11.48% from the prior year.
- Other Non-Current Assets was $65.7 million for Q2 2026 at Omnicell, down from $67.5 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $122.1 million in Q1 2022 and troughed at $65.7 million in Q2 2026.
- A 5-year average of $88.1 million and a median of $84.7 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets rose 3.1% in 2022 and decreased 17.88% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $105.0 million in 2022, then slipped by 13.86% to $90.5 million in 2023, then declined by 12.34% to $79.3 million in 2024, then slipped by 11.48% to $70.2 million in 2025, then dropped by 6.48% to $65.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $65.7 million (Q2 2026), $67.5 million (Q1 2026), and $70.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 457.39 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 65.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.66 Mn |
| Mar 31, 2026 | 67.55 Mn |
| Dec 31, 2025 | 70.20 Mn |
| Sep 30, 2025 | 70.09 Mn |
| Jun 30, 2025 | 72.03 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | 79.31 Mn |
| Sep 30, 2024 | 81.73 Mn |
| Jun 30, 2024 | 83.05 Mn |
| Mar 31, 2024 | 86.32 Mn |
| Dec 31, 2023 | 90.47 Mn |
| Sep 30, 2023 | 90.77 Mn |
| Jun 30, 2023 | 96.79 Mn |
| Mar 31, 2023 | 100.47 Mn |
| Dec 31, 2022 | 105.02 Mn |
| Sep 30, 2022 | 110.35 Mn |
| Jun 30, 2022 | 117.86 Mn |
| Mar 31, 2022 | 122.12 Mn |
| Dec 31, 2021 | 127.52 Mn |
| Sep 30, 2021 | 120.48 Mn |